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Abstract  1 
There is increasing evidence that local thyroid hormone (TH) availability changes profoundly in 2 
inflammatory conditions due to altered expression of deiodinases that metabolize TH.  It is largely 3 
unknown, however, how inflammation affects TH availability via the expression of TH transporters.  In 4 
this study we examined the effect of bacterial lipopolysaccharide (LPS) administration on two TH 5 
transporters that are critically important for brain TH homeostasis, organic anion-transporting polypeptide 6 
1c1 (OATP1c1) and monocarboxylate transporter 8 (MCT8).  Messenger RNA levels were studied by in 7 
situ hybridization and quantitative PCR, and protein levels by immunofluorescence in both the rat and 8 
mouse forebrain.  The mRNA of both transporters decreased robustly in the first 9h after LPS injection, 9 
selectively in brain blood vessels; OATP1c1 mRNA in astrocytes and MCT8 mRNA in neurons remained 10 
unchanged.  At 24 and/or 48h after LPS administration, OATP1c1 and MCT8 mRNAs increased 11 
markedly above control levels in brain vessels.  OATP1c1 protein decreased markedly in vessels by 24h, 12 
whereas MCT8 protein levels did not decrease significantly.  These changes were highly similar in mice 13 
and rats.  The data demonstrate that OATP1c1 and MCT8 expression are regulated in a parallel manner 14 
during inflammation at the blood-brain barrier of rodents.  Given the indispensable role of both 15 
transporters in allowing TH access to the brain, the results suggest reduced brain TH uptake during 16 





It is well known that thyroid hormone (TH) homeostasis is altered in association with acute and chronic 2 
illnesses, a disorder commonly referred to as the nonthyroidal illness syndrome and manifested by 3 
reduced serum TH levels and an inappropriately low TSH (1-3).  However, there is limited understanding 4 
about how TH availability changes at the level of specific target cells and tissues under these conditions.  5 
Local TH availability is largely determined by the presence of TH transporters that enable the passage of 6 
TH across cellular membranes, and deiodinases that metabolize TH (4, 5).  Deiodinases have been studied 7 
extensively in animal models of inflammatory conditions (1), particularly type 2 deiodinase (D2) that 8 
activates T4 to the biologically more potent T3 (4).  In these models, D2 expression increases in several 9 
organs (6-15), including novel expression in cells and tissues where it is not normally present (6, 8, 15), 10 
suggesting a local anti-inflammatory role for TH (6, 8, 16-18).  In contrast, it is largely unknown how 11 
inflammation affects TH availability via TH transporters.  Quantitative PCR studies reported decreased 12 
monocarboxylate transporter 8 (MCT8, coded by Slc16a2) expression in several organs of septic pigs (19) 13 
and in the subcutaneous fat of septic patients (20), while organic anion-transporting polypeptide 1c1 14 
(OATP1c1, coded by Slco1c1) and monocarboxylate transporter 10 (MCT10) mRNAs increased in the 15 
hypothalamus of rabbits in prolonged critical illness (21).  Details of these responses, such as cell-type 16 
specificity, temporal characteristics, and whether mRNA changes translate into protein levels, have not 17 
yet been studied.  Shedding light on these aspects of TH handling would be important to better understand 18 
TH availability during disease at the cellular level. 19 
Previously, we described how inflammation affects D2 expression in the brain of different rodent species, 20 
and demonstrated inflammation-induced D2 expression in the leptomeninges, choroid plexus and a subset 21 
of brain blood vessels (15).  The present study was conducted to obtain a detailed, cell-type-specific 22 
insight into the inflammatory regulation of TH transporters.  Of the several proteins capable of TH 23 
transport and present in the rodent brain (22, 23), we focused on OATP1c1 and MCT8 because they are 24 
critically important for brain TH homeostasis (24).  Both transporters facilitate TH traffic in multiple cell 25 
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types (25-30), and are indispensable for TH entry into the brain via the blood-brain and/or blood-1 
cerebrospinal fluid barrier (24, 31-34).  In fact, almost the entire T3 uptake into the brain is facilitated by 2 
MCT8 (32), while both MCT8 and OATP1c1 contribute to T4 uptake (24).  Importantly, a recent study 3 
by Mayerl et al. (24) demonstrated that the lack of both transporters results in a severely hypothyroid 4 
brain, with T3 and T4 contents being of only 10% of wild type levels. 5 
In this study, we examined the effect of bacterial lipopolysaccharide (LPS) administration, an acute 6 
systemic inflammatory challenge, on OATP1c1 and MCT8 mRNA and protein expression in the brain 7 
using in situ hybridization, quantitative PCR, and immunofluorescence.  Since we previously found major 8 
differences in the LPS-induced D2 expression between rats and mice (15), we performed the experiments 9 
in both species, with special attention to the rat meninges. 10 
 11 
Materials and Methods 12 
Animals 13 
The experiments were carried out on adult, male, Sprague-Dawley (Taconic Farms) and Wistar rats 14 
(TOXI-COOP KKT, Hungary) weighing 220-260g, and adult, male C57Bl/6 mice (Taconic and Charles 15 
River), weighing 19-21 g.  Animals were housed under standard conditions (lights on between 0600 and 16 
1800 h, temperature 22 ± 1 C, rodent chow and water ad libitum).  All experimental protocols were 17 
reviewed and approved by the Institutional Animal Care and Use Committee at Tufts Medical Center and 18 
the Animal Welfare Committee at the Institute of Experimental Medicine of the Hungarian Academy of 19 
Sciences. 20 
 21 
Injections and tissue preparation 22 
LPS-injections: Rats and mice were injected ip with LPS from Escherichia coli (serotype O55:B5; 23 
Sigma-Aldrich Co), dissolved in saline, at a dose of 2.5 mg/kg body weight to all animals according to the 24 
Guide of the American Thyroid Association (35).  Control animals received the same volume of saline. 25 
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Experiment for quantitative PCR analysis: Groups of Wistar rats (n=6 per group) and C57Bl/6 mice (n=8 1 
per group) were injected with LPS or saline, and were decapitated 9 or 48h later. The brains were 2 
dissected and samples from the cerebral cortex collected and stored at −80°C until subjected to real-time 3 
PCR.  In another experiment, leptomeninges of the basal forebrain were collected from 6 control and 8 4 
LPS-treated Sprague-Dawley rats 9h after the injections. 5 
Time course experiment for in situ hybridization and immunofluorescence studies: Groups of Sprague-6 
Dawley rats and C57Bl/6 mice (n=4 or 5 in each group) were injected with LPS and 2, 4, 9, 24 or 48h 7 
later were anesthetized with ketamine-xylazine, then decapitated.  Control mice (n=5) were euthanized at 8 
9h, and control rats were euthanized at 9h (n=3) or 24h (n=2), as in situ hybridization and 9 
immunofluorescent signals for OATP1c1 and MCT8 were of the same intensity in 9h and 24h control rat 10 
brains.  The brains were removed, snap-frozen on powdered dry ice and 16 μm thick coronal sections 11 
were cut using a Leica CM3050 S cryostat (Leica Microsystems).  Sections were thaw-mounted on 12 
Superfrost Plus slides (Fisher Scientific Co), air-dried and stored at -80°C until processed for in situ 13 
hybridization. 14 
 15 
RNA isolation and Real time PCR analyses  16 
RNA was isolated using the RNeasy Lipid Tissue Mini Kit (Qiagen) from cortex samples and with 17 
RNeasy Tissue Mini Kit (Qiagen) from leptomeninges according to the manufacturer’s instructions. The 18 
purity and concentration of the RNA were analyzed using Spectrophotometer (Bio-Rad, SmartSpec Plus). 19 
Reverse transcription was performed with 1 μg of RNA to convert the total RNA to cDNA using the High 20 
Capacity cDNA Reverse Transcriptase Kit (Applied Biosystems by Life Technologies). Concentration of 21 
the generated cDNA was determined using the Qubit 2.0 Fluorometer with the Qubit ssDNA Assay Kit 22 
(Life Technologies). Expression of OATP1c1, MCT8 and D2 was measured by real-time quantitative 23 
TaqMan RT PCR reaction with a ViiA 7 Real-Time PCR System (Life Technologies), using 24 
commercially available TaqMan probes (code numbers are summarized in Supplementary Table 1.) on 10 25 
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ng cDNA template in duplicates. Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) was used as 1 
housekeeping gene. Expression of the housekeeping gene did not vary between the experimental groups.  2 
 3 
Generation of hybridization probes 4 
Template cDNA fragments were generated with RT-PCR using standard procedures. Amplification was 5 
performed on cDNA synthesized from rat brain for OATP1c1 and mouse or rat liver for MCT8. 6 
Fragments were cloned into pGemT vector (Promega) and confirmed by sequencing.  Probe sequences 7 
were as follows: rat OATP1c1 probe corresponds to nt 375-2525 of NM_053441.1 and has 93% 8 
homology with the corresponding mouse sequence, nt 368-2522 of NM_021471.2; mouse MCT8 probe nt 9 
2569-3428 of NM_009197.2; rat MCT8 probe nt 41-648 of NM_147216.1, and has 98% homology with 10 
the mouse sequence NM_009197.2 between nt 227-834; rat D2 probe was reported previously (15).  11 
Antisense riboprobes were synthesized using SP6 or T7 RNA polymerase (Promega) in the presence of 12 
[35S]-uridine 5′-(alpha-thio) triphosphate (PerkinElmer), and purified with Mini Quick Spin RNA 13 
columns (Roche Applied Sciences).  For fluorescent in situ hybridization, the OATP1c1 probe was 14 
labeled with digoxigenin-11-UTP (Roche). 15 
 16 
Isotopic in situ hybridization 17 
Isotopic in situ hybridization was performed as previously described (15, 36) using 50,000 cpm/μl 18 
radiolabeled probe concentrations.  The same probe was used to detect OATP1c1 mRNA in both species; 19 
the rat MCT8 probe was used for rat sections, while both the rat and mouse MCT8 probes that are non-20 
overlapping were used on mouse sections to increase hybridization sensitivity.  Following stringency 21 
washes, sections were dehydrated in ascending ethanol series, air-dried, and placed on Amersham 22 
Hyperfilm autoradiography film (GE Healthcare Biosciences) for 6 days (rat OATP1c1) or 8 days (mouse 23 
OATP1c1 and MCT8).  Slides were then dipped in Kodak NTB autoradiography emulsion (Carestream 24 
Health Inc), and stored at 4°C until developed.  Exposure times were as follows: 9 days for mouse 25 
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OATP1c1; 24 days for mouse MCT8; two exposure times, 5 days and 9 days, were used for two different 1 
hybridizations for rat OATP1c1; 35 days for rat MCT8; and 14 days for rat D2.  Autoradiograms were 2 
developed with Kodak D19 developer (Eastman Kodak Co).  Sections were immersed in 0.0005% cresyl 3 
violet acetate (Sigma-Aldrich) for 2 min to obtain fluorescent labeling of cell nuclei, dehydrated in 4 
ascending ethanol series and xylenes, and coverslipped with DPX (Sigma-Aldrich).  Darkfield images of 5 
the emulsion autoradiographs and fluorescent images of the cresyl violet signal were captured using a 6 
Zeiss Axioplan 2 microscope equipped with a SPOT Slider digital camera (Diagnostic Instruments).  7 
 8 
Isotopic OATP1c1 in situ hybridization combined with GFAP immunofluorescence 9 
Sections from the control and 9h LPS groups from both species were hybridized for OATP1c1 as above, 10 
then processed further for immunofluorescence.  The sections were treated with the mixture of 0.5% 11 
Triton X-100 and 0.5% H2O2 for 15 min, rinsed in PBS (3×10 min), immersed in maleate buffer (pH 7.5) 12 
for 10 min, and then in 1% blocking reagent for nucleic acid hybridization (Roche).  The sections were 13 
incubated overnight in a mouse monoclonal antibody against the astrocyte marker, glial fibrillary acidic 14 
protein (GFAP) (Cat# MAB360, Millipore, diluted 1:1,000), and subsequently in Alexa Fluor 488-15 
conjugated donkey anti-mouse IgG (1:400; Life Technologies) for 2 hours.  Sections were dehydrated and 16 
dipped in Kodak NTB autoradiography emulsion.  The autoradiograms were developed after 9 days.  The 17 
fluorescent signal of Alexa Fluor 488 was pseudo-colored to red for better visibility of dual-labeled cells. 18 
 19 
Fluorescent OATP1c1 in situ hybridization combined with GFAP immunofluorescence 20 
Hybridizations were performed on both fresh-frozen control rat sections, and sections from four normal 21 
paraformaldehyde-perfused rats.  Paraformaldehyde-perfusion was performed as previously described 22 
(36).  Briefly, rats were anesthetized with an overdose of pentobarbital (50 mg/kg) and perfused 23 
transcardially with PBS followed by 4% paraformaldehyde.  The brains were postfixed by immersion in 24 
4% paraformaldehyde, cryoprotected in 20% sucrose in PBS overnight, then snap-frozen on dry ice.  25 
Serial 20 μm coronal sections were cut on a cryostat, collected in cryoprotectant solution and stored at -26 
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20°C until used.  Fluorescent in situ hybridization for fresh-frozen and paraforaldehyde-perfused sections 1 
was performed as previously described (15, 36).  The digoxigenin-labeled probe was detected with 2 
peroxidase-conjugated Fab fragments of sheep anti-digoxigenin antibody (1:100, Roche).  The 3 
hybridization signal was amplified with biotinylated tyramide for 30 min using the TSA amplification kit 4 
(Perkin Elmer), and visualized by Alexa 488-conjugated Streptavidin (1:500; Life Technologies).  5 
Sections were reacted with murine GFAP antibody as above, and detected with Cy3-conjugated donkey 6 
anti-mouse IgG (Jackson ImmunoResearch).  Sections were then coverslipped with Vectashield 7 
containing 4′,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories). 8 
 9 
Immunofluorescence for OATP1c1 and MCT8 10 
For MCT8 immunofluorescence, mounted fresh-frozen sections were fixed with 4% paraformaldehyde in 11 
0.1M phosphate buffer (pH 7.4) for 15 min.  For OATP1c1 immunofluorescence, sections were fixed 12 
with methanol at −20°C for 5 min.  Sections were permeabilized with 0.25% Triton-X-100 for 30 min, 13 
blocked with 2% normal horse serum in PBS, and incubated overnight in a rabbit antiserum against 14 
human MCT8 (raised against amino acids 527-539; #1306, gift from Dr. Theo J. Visser) or a rabbit 15 
antiserum against human OATP1c1 (raised against amino acids 697-712; #3516, gift from Dr. Theo J. 16 
Visser), both diluted at 1:1,000.  The primary antisera were detected with Alexa Fluor 488-conjugated 17 
donkey anti-rabbit IgG diluted at 1:400 (Jackson Immunoresearch).  Immunostaining with both antisera 18 
resulted in the same patterns reported earlier (26, 37).   19 
 20 
Image analysis 21 
In situ hybridization signals were compared between sections from a single hybridization experiment 22 
where all conditions and exposure times were identical.  Darkfield images of OATP1c1 in situ 23 
hybridization were analyzed with ImageJ software (public domain at http://rsb.info.nih.gov/ij).  To 24 
maximize the analysis of OATP1c1 signal in blood vessels, hybridizations were analyzed in the 25 
hypothalamus where no significant signal was detected in astrocytes after 9 days exposure in mice or 5 26 
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days exposure in rats.  Images were taken with a 5× objective at the level of the paraventricular nucleus 1 
(mice) or the dorsomedial nucleus (rats), and integrated density values were calculated.  From the two rat 2 
OATP1c1 hybridizations, only the 5 day exposure experiment was used for quantitative image analysis.  3 
Images from both the 9 and 5 days exposure experiments were used to illustrate the magnitude of changes 4 
in OATP1c1 hybridization signal.  To quantify vascular MCT8 hybridization in mice, blood vessel 5 
segments with clear hybridization signal were counted in the thalamus and hypothalamus in 3 sections per 6 
mouse at the rostro-caudal level of the median eminence.  In these regions, the low neuronal hybridization 7 
signal allowed easier identification of labeled blood vessels than in cortical regions.  OATP1c1 8 
immunofluorescence in blood vessels was quantified in rats using ImageJ.  Images were taken with a 20× 9 
objective of an area with high density of blood vessels in the midline thalamus.  The area covered by 10 
immunofluorescently labeled vessels (pixel number) was measured by subtracting non-labeled areas (i.e., 11 
dark pixels) from the image using the threshold tool and the same threshold value for all images.  12 
Hematoxylin and eosin staining was used to facilitate the identification of arachnoid veins in rats. 13 
 14 
Statistical analysis 15 
Data are presented as mean ± SEM.  Quantitative PCR data were expressed as RQ (mean +/- SEM). 16 
Quantitative PCR data from cortex and image analysis data were compared between groups by one-way 17 
ANOVA and Newman-Keuls multiple comparison post-hoc test. Quantitative PCR data from the 18 
leptomeninges were compared by Student’s t test.  19 
 20 
Results 21 
Effect of LPS on OATP1c1 expression in the brain 22 
OATP1c1 mRNA. LPS administration similarly affected OATP1c1 expression in mice and rats.  23 
OATP1c1 mRNA levels decreased profoundly within 9h after LPS injection, as demonstrated by a 24 
striking reduction in hybridization signal across the forebrain (Fig. 1A, 1B).  Emulsion autoradiography 25 
revealed that this reduction was due to a loss of hybridization signal specifically in blood vessels, but not 26 
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astrocytes. Vascular OATP1c1 expression decreased uniformly in the forebrain, but the course of this 1 
response could be followed most clearly in the hypothalamus (Fig. 2A) where hybridization signal in 2 
astrocytes was the lowest among forebrain regions.  Hybridization signal in vessels decreased 3 
significantly as soon as 2h after LPS, and markedly by 4h (Fig. 2A).  Vascular hybridization signal was 4 
virtually absent in mice 9h after LPS injection, except light labeling of the highly vascularized 5 
hypothalamic paraventricular nucleus (Fig. 2A).  A similar reduction was observed in rats, where only 6 
scattered blood vessels with light hybridization signal were detected at 9h after LPS (in the hybridization 7 
experiment with the longer, 9 day autoradiography exposure).  Moderate labeling remained only in some 8 
vessels of the paraventricular and supraoptic nuclei (Fig. 3A; also in Fig 1A); in fact, vessels in these two 9 
nuclei were more intensely labeled than elsewhere, even in control rats.  The loss of OATP1c1 10 
hybridization signal in blood vessels is also demonstrated in images from the cerebral cortex in Figs. 2B 11 
and 3A.   12 
Hybridization signal in astrocytes did not change noticeably in either species, and remained comparable 13 
to control levels 9h after LPS, as demonstrated in images from the mouse and rat cortex (Fig. 2B, 3A).  14 
Notably, OATP1c1 mRNA in astrocytes varied greatly between brain regions, confirming recent studies 15 
(23, 27).  In mice, OATP1c1 mRNA was easily detected in hippocampal and cortical astrocytes, while it 16 
was not detected in hypothalamic astrocytes with the exposure time used in this experiment.  In rats, 17 
differences in astrocytic OATP1c1 expression were confirmed by both fluorescent (Fig. 3B) and 18 
radioactive in situ hybridization.  Hybridization signal was moderate to intense in astrocytes of the cortex, 19 
hippocampus, striatum, and ventrolateral thalamus, whereas it was much lighter in astrocytes of the 20 
hypothalamus, such as in the ventromedial nucleus (Fig. 3B).   21 
In both species, vascular OATP1c1 hybridization signal increased above control levels during the 22 
recovery phase from endotoxemia.  In mice, OATP1c1 mRNA was still below control levels at 24h, but 23 
increased markedly at 48h after LPS (Fig. 2A).  In rats, upregulation of OATP1c1 mRNA in blood 24 
vessels could be observed at both 24h and 48h after LPS (Fig. 3A).  Conspicuously increased signal in 25 
vessels was observed in one out of four rats in the 24h LPS group, and three out of four rats in the 48h 26 
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LPS group.  Markedly increased OATP1c1 mRNA at 24h after LPS was confirmed in another experiment 1 
(2 out of 2 rats; data not shown).  This indicates that the timing of post-endotoxemic increase in vascular 2 
OATP1c1 mRNA can vary among individual rats.  Image analysis results from mice and rats representing 3 
vascular OATP1c1 mRNA expression at each time point following LPS injection are presented in Fig. 4 
4A.  Quantitative RT-PCR data from cortical samples confirmed the in situ hybridization results, as 5 
OATP1c1 mRNA was significantly decreased 9h after LPS injection in both species (Fig. 4B).  At 48h 6 
after LPS, OATP1c1 mRNA levels were not different from control levels by quantitative PCR (Fig. 4B).  7 
In the choroid plexus, OATP1c1 hybridization signal was consistently reduced 9h after LPS in mice (Fig. 8 
1B), but not rats.  In tanycytes, OATP1c1 mRNA expression was extremely intense in rats (Supplemental 9 
Fig. 1), but conspicuously absent in mice (Supplemental Fig. 2).  LPS did not affect OATP1c1 expression 10 
in rat tanycytes. 11 
OATP1c1 protein. Immunofluorescence for OATP1c1 gave clear labeling of blood vessels in the rat brain 12 
with low background, whereas in mice the labeling was less sensitive and less clear due to higher 13 
background levels.  The antiserum did not label astrocytes.  Immunostaining of blood vessels did not 14 
differ between control, 2h and 4h LPS groups, but visibly decreased at 9h and 24h (5A, 5B).  At 24h, 15 
when the decrease was significant by image analysis (Fig. 4A), only scattered major vessel segments were 16 
labeled in both species (Fig. 5A, 5B).  OATP1c1 immunostaining in vessels at 48h after LPS was similar 17 
to controls (Fig. 5A, 5B).  OATP1c1 immunostaining was intense in rat tanycytes (Supplemental Fig. 1), 18 
whereas in mice it was observed selectively in lateral beta (beta-1) tanycytes in the floor of the third 19 
ventricle (Supplemental Fig. 2).  The presence of OATP1c1 immunoreactivity in mouse tanycytes is in 20 
agreement with a previous report by Roberts et al. (26) that used highly specific antibodies. 21 
 22 
Effect of LPS on MCT8 expression in the brain 23 
MCT8 mRNA. LPS similarly affected MCT8 expression in mice and rats.  The hybridization patterns in 24 
control brains were identical to what was previously described (25).  Several neuronal populations were 25 
labeled with variable, light to intense signal, and scattered larger blood vessels were labeled with 26 
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moderate or light signal (Fig. 1C).  Rat tanycytes were intensely labeled, and extremely intense signal 1 
labeled mouse tanycytes and the choroid plexus in both species (Fig. 1C).  Neuronal MCT8 expression 2 
did not noticeably change at any time after LPS injection in both species (Fig. 1C).  In contrast, MCT8 3 
mRNA expression in blood vessels changed markedly in response to LPS.  In mice, the intensity of 4 
vascular labeling decreased gradually from 2h until 9h, when hybridization signal was no longer detected 5 
in vessels (Fig. 6A).  A similar trend was observed in rats, with noticeably less numerous and less 6 
intensely labeled blood vessels at 4h, and only occasional, lightly labeled vessels visible at 9h (Fig. 6B). 7 
In mice, both the number of detected vessel segments and their signal intensity increased at 24h after LPS 8 
compared to control mice, and even more strikingly at 48h (Fig. 1C, 6A).  The quantification of labeled 9 
vessels in mice is presented in Fig. 4A.  In rats, labeling of blood vessels was comparable to control levels 10 
at 24h, but increased markedly by 48h after LPS (Fig. 6B).  Quantitative PCR from the mouse cortex did 11 
not detect significant changes in MCT8 mRNA after LPS (Fig. 4B).  In the rat cortex, MCT8 mRNA 12 
tended to decrease at 9h albeit not significantly, but significantly increased 48h after LPS (Fig. 4B).   13 
MCT8 protein. MCT8 immunolabeling in blood vessels was not different from control levels at 2, 4, 9 or 14 
48h after LPS in both species.  Only a slight decrease in labeling was observed at 24h in mice (Fig. 5C). 15 
Intense MCT8 immunofluorescence was observed in axons in both species, in accordance with our 16 
previous description of specific axonal MCT8 labeling (37).  MCT8-containing axons were present in 17 
most brain regions, but unaffected by LPS. 18 
 19 
Effect of LPS on OATP1c1, MCT8 and D2 mRNAs in the rat leptomeninges 20 
Since we previously observed that LPS administration induces robust D2 expression in the leptomeninges 21 
of rats (15), we also studied the expression of TH transporters in this tissue.  OATP1c1 mRNA-22 
expressing cells were observed in arachnoid veins, but not arteries or in the arachnoid tissue itself (Fig. 23 
7A).  Following LPS, OATP1c1 hybridization signal could no longer be detected in the wall of the veins 24 
at 2, 4 or 9h later (Fig. 7A), but returned to control levels by 24h, and remained normal at 48h.   25 
Conversely, D2 mRNA was induced in the wall of the arachnoid veins but not arteries following LPS (Fig 26 
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7A), which we did not previously recognize (15).  Moderate to intense MCT8 hybridization signal was 1 
observed in the leptomeningeal layers between the hippocampus and thalamus (Fig. 7A), and the dorsal 2 
third ventricle adjacent to the choroid plexus.  This signal did not change significantly following LPS 3 
administration.  MCT8 hybridization signal in the arachnoid covering the outer brain surface was 4 
uncertain, as control hybridizations with the sense transcript also yielded labeling in this location, 5 
although less intensely than the antisense probe.  By quantitative PCR from leptomeninges removed from 6 
the basal forebrain, OATP1c1 mRNA was reduced to approximately 10% of control level 9h after LPS 7 
injection, MCT8 mRNA did not change, while D2 mRNA increased 86-fold on average (Fig. 7B). 8 
 9 
Discussion 10 
While data have been accumulating on cell-type specific regulation of TH action in the brain, regulation 11 
of TH transport is poorly understood.  In the present study, regulation of TH transporters was studied in 12 
the forebrain using a model of non-thyroidal illness syndrome, a condition known to evoke marked 13 
changes in tissue TH availability (1, 2).  In particular, we report changes in OATP1c1 and MCT8 14 
expression in the rodent brain in response to LPS administration, with the following main findings: 1) 15 
OATP1c and MCT8 mRNAs decrease rapidly and robustly in blood vessels; 2) this effect is cell-type 16 
specific as OATP1c1 and MCT8 mRNA levels remain unaltered in astrocytes and neurons; 3) a robust 17 
decrease in OATP1c1 but not MCT8 protein levels in vessels follows hours later; 4) during recovery from 18 
endotoxemia, OATP1c1 and MCT8 mRNA levels increase markedly in blood vessels above control 19 
levels; 5) these changes occur in both mice and rats.  In addition, we describe OATP1c1 expression in 20 
arachnoid veins but not arteries that respond to LPS in a similar way as parenchymal blood vessels, and 21 
MCT8 mRNA in part of the rat leptomeninges. 22 
MCT8 and OATP1c1 have complementary functions in the blood-brain barrier, and work in tandem to 23 
allow TH access to the brain (24).  The parallel changes in OATP1c1 and MCT8 mRNAs in brain vessels 24 
during endotoxemia further corroborates the functional link between these transporters, and suggest a 25 
common mechanism regulating the expression of these genes during inflammation.  The mechanisms by 26 
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which rapid downregulation of both transporter mRNAs occurs is unknown, but could be a direct effect of 1 
cytokines or other associated inflammatory signals that are associated with endotoxin administration.  2 
However, this response was specific to cells comprising the brain vasculature, such as endothelial cells 3 
known to express these transporters (26, 34, 38) and possibly also pericytes, while OATP1c1 and MCT8 4 
mRNA levels remained unchanged in astrocytes and neurons.  One possibility to explain the latter 5 
phenomenon is that the extracellular signal that down-regulates MCT8 and OATP1c1 expression in 6 
vessels has limited access to astrocytes and neurons inside the blood-brain barrier.  Alternatively, the 7 
signal may be present in the brain parenchyma, but due to intrinsic properties of astrocytes and neurons, 8 
has no effect on OATP1c1 or MCT8 mRNA.  The latter might be explained by the lack of receptors for 9 
the signal molecule, or that the signaling pathway activated is not coupled to the mechanism that changes 10 
the transcription of the transporter genes. 11 
The marked increase in OATP1c1 and MCT8 mRNAs during the recovery period from endotoxemia may 12 
be secondary to low intracellular TH levels in microvascular cells, supported by data that OATP1c1 in rat 13 
brain microvessels is upregulated by hypothyroidism (28).  However, regulation of OATP1c1 and MCT8 14 
mRNAs by TH was not observed in congenitally hypothyroid mice (25), raising the possibility that 15 
increased OATP1c1 and MCT8 mRNA expression may be a rebound effect independent of TH 16 
concentration. 17 
At the protein level, OATP1c1 decreased in brain vessels in a similarly robust manner as OATP1c1 18 
mRNA, but only several hours later.  This delay likely reflects the turnover rate of OATP1c1 protein in 19 
cells of the blood-brain barrier.  In contrast, only a modest decrease in vascular MCT8 immunostaining 20 
was observed in mice.  A possible explanation is that the half-life of MCT8 may be substantially longer 21 
than that of OATP1c1, and in our model, the inflammatory state may have been too transitory to see a 22 
significant decrease in the MCT8 protein.  Thus, an inflammation model of longer duration may be 23 
necessary to more definitively address whether MCT8 decreases similar to OATP1c1.  Since our analysis 24 
did not provide information on the subcellular location of the transporters, it is also conceivable that 25 
15 
 
internalization of OATP1c1 and/or MCT8 from the cell membrane could result in a more rapid decrease 1 
in TH transport before a decrease in protein levels is realized. 2 
Access of TH to most of the brain parenchyma primarily occurs via the blood-brain barrier, and much less 3 
via the blood-cerebrospinal fluid barrier (39).  Since deficiency in either OATP1c1 or MCT8 is sufficient 4 
to reduce brain TH uptake (24, 32), downregulation of these transporters in brain vessels during 5 
inflammation suggests diminished TH uptake into the brain parenchyma and may contribute to common 6 
symptoms associated with illness such as fatigue, depressed mood, and impaired neurocognitive function.  7 
In support, a recent clinical study reported that certain OATP1c1 polymorphisms are associated with 8 
fatigue and depression in a population of patients with adequately treated hypothyroidism (40).  9 
Inflammatory regulation of OATP1c1 and MCT8 was strikingly different from that observed for D2 that 10 
is highly inducible by the inflammatory transcription factor, nuclear factor-kappa B (NF-κB) (11, 41).  11 
LPS induces D2 via NF-κB in tanycytes (7, 15), and probably in meningeal fibroblasts (15).  In contrast, 12 
OATP1c1 and MCT8 expression did not increase following LPS in any cell type in the brain, and 13 
markedly decreased in cells of brain blood vessels.  The opposite regulation of D2 and OATP1c1/MCT8 14 
by inflammation raises the possibility that during inflammation, TH availability may not be uniform 15 
throughout the brain.  The downregulation of OATP1c1 and MCT8 at the blood-brain barrier suggests 16 
decreased TH availability within the brain parenchyma, whereas induction of D2 suggests increased TH 17 
availability in the leptomeninges and choroid plexus (15).  Therefore, inflammation may result in both 18 
“hypothyroid” and “hyperthyroid” compartments in the rat brain.  As we previously hypothesized (15), 19 
increased TH levels in the leptomeninges and choroid plexus, where the proinflammatory reaction is the 20 
most intense following LPS administration (42-47), may serve to control inflammatory processes and 21 
improve macrophage function (6, 8, 16-18).  It can be also speculated, however, that at the same time 22 
decreased TH levels might be adaptive for cells in the brain parenchyma.  While further research will be 23 
necessary to understand the pathophysiological role of these changes, the present findings underscore that 24 
TH availability may differ significantly for different cell types of a single organ during the non-thyroidal 25 
illness syndrome. 26 
16 
 
In conclusion, OATP1c1 and MCT8 expression is downregulated in the blood-brain barrier during 1 
inflammation, suggesting decreased TH uptake into the rodent brain.  TH uptake studies in inflammation 2 
models will be essential in the future to test the importance of TH transporter downregulation on TH 3 
delivery to the brain. 4 
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 Figure legends 5 
 6 
Figure 1. X-ray film autoradiograms of isotopic in situ hybridizations for rat and mouse OATP1c1, and 7 
mouse MCT8.  (A) OATP1c1 mRNA expression in the rat forebrain in the function of time following 8 
LPS injection.  Hybridization signal decreases after LPS injection; at 4 and 9h, the remaining visible 9 
signal in the hypothalamic paraventricular and supraoptic nuclei is vascular, while in other regions, such 10 
as the hippocampus and cortex, is primarily astrocytic.  (B) LPS has the same effect on OATP1c1 mRNA 11 
in mice as in rats.  In mice, OATP1c1 mRNA decreases even in the choroid plexus at 9h.  (C) MCT8 12 
mRNA in the mouse brain following LPS administration. Neuronal labeling remains unchanged.  The 13 
bottom panel shows magnified views of the diencephalic area, where several labeled blood vessels 14 
(arrowheads) are visible at 24h and 48h, but none at 9h after LPS.  cp, choroid plexus; Hip, Hippocampus; 15 
PVH, hypothalamic paraventricular nucleus; tan, tanycytes; SO, supraoptic nucleus; VMH, hypothalamic 16 
ventromedial nucleus.  Scale bars = 2mm. 17 
 18 
Figure 2. (A) Darkfield emulsion autoradiography images demonstrate the time course of OATP1c1 19 
mRNA expression (silver grain accumulation, white) in the mouse hypothalamus after LPS injection.  20 
Hybridization signal labeled only blood vessels but not astrocytes in the hypothalamus. The signal 21 
virtually disappears by 9h, when only light signal remains visible in the paraventricular nucleus (PVH).  22 
At 48h, OATP1c1 mRNA increases significantly. Scale bar = 200µm. (B) Combination of in situ 23 
hybridization for OATP1c1 (silver grains) and GFAP immunofluorescence (red) demonstrates that LPS 24 
did not affect OATP1c1 mRNA expression in astrocytes.  Images were taken from the piriform cortex 25 
(control) and adjacent cortical amygdala (LPS).  White arrows in the overlay images indicate astrocytes 26 
23 
 
with OATP1c1 hybridization signal, open arrows point to blood vessel segments.  Note that hybridization 1 
signal labels vessel segments in the control, but not in LPS-injected brain. Scale bar = 50µm. 2 
 3 
Figure 3. (A) Darkfield emulsion autoradiography images illustrate the effect of LPS on OATP1c1 4 
mRNA in the rat brain.  The decrease in OATP1c1 mRNA levels at 9h is demonstrated in hybridizations 5 
with longer exposure time, while shorter exposure was necessary to visualize the increase at 48h. The top 6 
panel shows the dramatic decrease of OATP1c1 mRNA in vessels of the hypothalamic paraventricular 7 
nucleus (PVH).  Middle panel demonstrates the effect in the cortex, where hybridization in vessels is 8 
almost completely absent 9h after LPS, and the remaining signal labels predominantly astrocytes.  Arrows 9 
indicate longer vessel segments in the control cortex.  The bottom panel demonstrates the robust increase 10 
in OATP1c1 mRNA levels in blood vessels at 48h after LPS; images were taken from the hypothalamic 11 
dorsomedial nucleus.  PVH, hypothalamic paraventricular nucleus.  Scale bar = 100 µm. (B) Fluorescent 12 
in situ hybridization demonstrates OATP1c1 mRNA in different astrocyte populations in the rat.  13 
Hybridization on paraformaldehyde-perfused sections shows high levels of OATP1c1 mRNA (green) in 14 
astrocytes of the hippocampus, cortex, and striatum.  Note the numerous intense green puncta denoting 15 
OATP1c1 mRNA in the cytoplasm and proximal processes of astrocytes, which were identified by 16 
immunofluorescence for GFAP (red).  In contrast, more sensitive hybridization using fresh-frozen 17 
sections was necessary to detect OATP1c1 mRNA in hypothalamic astrocytes.  In these cells, 18 
hybridization signal concentrated in only a few, 5-8, smaller sized puncta.  Cell nuclei are labeled by the 19 
blue fluorescence of DAPI. Scale bar = 20 µm.  20 
 21 
Figure 4. (A) Results of semiquantitative image analysis of OATP1c1 and MCT8 in situ hybridization, 22 
and OATP1c1 immunofluorescence.  OATP1c1 hybridization signal was quantified in the hypothalamus 23 
and represents mRNA expression specifically in blood vessels, as astrocytes were not labeled with the 24 
used exposure times.  In the mouse MCT8 in situ hybridization experiment, the number of labeled blood 25 
vessels were counted in the diencephalic area in 3 sections per mouse, and the average number of vessels 26 
24 
 
per section was calculated and presented in the graph.  OATP1c1 immunofluorescence in rats was 1 
quantified in images taken from the thalamus by measuring the area (pixel number) covered by 2 
immunolabeled vessels. Sample sizes: 4 or 5 rats or mice/group.  * P < 0.05;  ** P < 0.01; *** P < 0.001 3 
vs control.  (B) Quantitative RT-PCR results from the mouse and rat cortex 9 and 48h after LPS injection. 4 
OATP1c1 mRNA is significantly reduced 9h after LPS injection in both species: In rats, MCT8 mRNA 5 
tended to decrease at 9h but did not reach significance (p= 0.07). Sample sizes: n=6 rats/group and 8 6 
mice/group.  * P < 0.05,  *** P < 0.001 vs the corresponding controls.  7 
 8 
Figure 5.  (A) OATP1c1 immunofluorescence shows the time course of OATP1c1 protein in blood 9 
vessels of rats following LPS injection.  Images were taken from the thalamus; note the decrease in 10 
labeling at 9h, and that only scattered vessel segments are labeled at 24h.  (B) The same phenomenon is 11 
shown in mice in images taken from the rostral perifornical area.  (C) MCT8 immunfluorescence in blood 12 
vessels of the mouse thalamus; labeling intensity is only mildly reduced at 24h after LPS.  Scale bar = 50 13 
µm. 14 
 15 
Figure. 6.  (A) Darkfield emulsion autoradiography images demonstrate the effect of LPS on MCT8 16 
mRNA in brain blood vessels.  Images were taken from the thalamus where labeled vessels (arrows) stand 17 
out due to virtually undetectable hybridization signal in neurons.  The vascular signal vanishes completely 18 
by 9h after LPS.  At 24h, and especially at 48h, more intense hybridization signal labels a higher number 19 
of vessels.  Scale bar = 200 µm.  (B) A similar phenomenon is illustrated in images taken from the rat 20 
hippocampus.  At 9h after LPS only occasional vessels with faint hybridization signal were detected, 21 
while several vessels with intense signal were observed at 48h.  Scale bar = 100 µm. 22 
 23 
Figure 7.  (A) In situ hybridization for OATP1c1, MCT8 and D2 in the rat leptomeninges.  Red 24 
fluorescent cresyl violet counterstaining is overlaid on darkfield emulsion autoradiography images to help 25 
identify tissue locations (OATP1c1 and D2 images).  Top: OATP1c1 mRNA is expressed specifically in 26 
25 
 
the wall of veins (v) that run in the arachnoid, but not in arteries (a), or the arachnoid tissue itself.  1 
Labeling of veins is absent 9h after LPS injection.  Bottom left: MCT8 mRNA is expressed in the 2 
leptomeningeal layers between the hippocampus and thalamus (arrows).  Bottom right: D2 mRNA is 3 
expressed in both the arachnoid tissue and wall of arachnoid veins (v), but not arteries (a) 9h after LPS 4 
injection.  a, artery; opt, optic tract; SO, supraoptic nucleus; v, vein.  Scale bar = 100µm in top, 200µm in 5 
bottom panels. (B) Quantitative RT-PCR results from rat leptomeningeal samples obtained from 6 control 6 
and 8 LPS-treated rats.  OATP1c1 mRNA decreases to 10% of control value, while D2 increases ~86-fold 7 
on average. * P < 0.05; *** P < 0.0001 vs control. 8 
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